Original Research
Published on 03 Sep 2024
Signal mining of adverse events of proteasome inhibitors in multiple myeloma based on FAERS
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1396378
- 842 views
Type at least 3 characters
1,947 articles
Articles
Original Research
Published on 03 Sep 2024
Drug-drug interaction between diltiazem and tacrolimus in relation to CYP3A5 genotype status in Chinese pediatric patients with nephrotic range proteinuria: a retrospective study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1463595
- 843 views
Original Research
Published on 02 Sep 2024
Antihypertensive drug-associated adverse events in osteoarthritis: a study of a large real-world sample based on the FAERS database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1404427
- 1,246 views
Original Research
Published on 30 Aug 2024
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1339721
- 781 views
Original Research
Published on 29 Aug 2024
Medication-related burden and its association with medication adherence among elderly tuberculosis patients in Guizhou, China: a cross-sectional study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1416005
- 612 views
Original Research
Published on 29 Aug 2024
Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipients
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1458838
- 696 views
Specialty Grand Challenge
Published on 26 Aug 2024
Drug outcomes research and policies – trends and challenges
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476849
- 853 views
Original Research
Published on 23 Aug 2024
Dexmedetomidine: a real-world safety analysis based on FDA adverse event reporting system database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1419196
- 1,108 views
Original Research
Published on 21 Aug 2024
Initial dosage optimization of olanzapine in patients with bipolar disorder based on model-informed precision dosing: a study from the real world
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1444169
- 703 views
Original Research
Published on 20 Aug 2024
Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362374
- 436 views
Review
Published on 19 Aug 2024
The burden of systemic therapy administration route in treating HER2-positive breast cancer (for patients, healthcare professionals, and healthcare system): a systematic literature review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1338546
- 1,111 views
Original Research
Published on 16 Aug 2024
Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1359568
- 697 views
Original Research
Published on 15 Aug 2024
Potentially inappropriate prescribing among older adults with hypertension in China: prevalence and related comorbidities across different outpatient settings
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1439230
- 684 views
Original Research
Published on 14 Aug 2024
Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1393559
- 962 views
Original Research
Published on 13 Aug 2024
Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1458438
- 2,089 views
Original Research
Published on 13 Aug 2024
Self-medication of adults and children in Poland - results from outpatient health care physicians online questionnaire
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413811
- 1,081 views